Clinical Trial Update: Post-Myocardial Infarction Remodeling Prevention Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a therapy to prevent adverse remodeling after acute myocardial infarction has completed, with results posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Acute Myocardial Infarction, Pacing Therapy | Phase 2 | Status: COMPLETED | Results posted: 2016-12-15